Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: Mystery resolved?

International Journal of Gynecological Pathology

Volumn 27, Issue 4, 2008, Pages 539-546

  Mhawech Fauceglia, Paulette ^a   Odunsi, Kunle ^a   Dim, Daniel ^a   Nowak, Norma ^a   Lele, Shashikant ^a   Cheney, Richard T ^a   Pejovic, Tanja ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

a CGH; Adenocarcinoma; Gynecologic tract; Neuroendocrine carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; DNA;

ADENOCARCINOMA; ARTICLE; CASE REPORT; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 12Q; CHROMOSOME 13; CHROMOSOME 15Q; CHROMOSOME 19Q; CHROMOSOME 2P; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 4P; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME LOSS; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE TUMOR; OVARY CARCINOMA; PRIORITY JOURNAL; CARCINOMA; CHEMISTRY; ENDOMETRIUM TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; OVARY TUMOR; PATHOLOGY;

ADENOCARCINOMA; CARCINOMA, NEUROENDOCRINE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS;

EID: 58149189087     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31816bcda4     Document Type: Article

References (38)

1. Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Am J Clin Pathol 2001;115(suppl 1):S94-112.
2. Schmidt D. Neuroendocrine tumors of the uterus. Verh Dtsch Ges Pathol 1997;81:260-5.
3. Ueda G, Yamasaki M. Neuroendocrine carcinoma of the uterus. Curr Top Pathol 1992;85:309-35.
4. Kupryjanczyk J. Neuroendocrine tumors of the ovary - a review. Verh Dtsch Ges Pathol 1997;81:253-9.
5. Eichhorn JH, Lawrence WD, Young RH, et al. Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature. Int J Gynecol Pathol 1996;15:303-14.
6. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for the identification of novel cancer-related genes. Cancer Sci 2004;95:559-63.
7. Weiss MM, Hermsen MA, Meijer GA, et al. Comparative genomic hybridization. J Clin Mol Pathol 1999;52:243-51.
8. Snijders AM, Nowak K, Segraves R, et al. Assembly of microarrays for genomic-wide measurement of DNA copy number. Nat Genet 2001;29:263-4.
9. Nowak NJ, Gaile D, Conroy JM, et al. Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 2005;161:36-50.
10. Cowell JK, Wang YD, Head K, et al. Identification and characterization of constitutional chromosome abnormalities using arrays of bacterial artificial chromosomes. Br J Cancer 2004;90:860-5.
11. Sharp AJ, Locke DP, McGrath SD, et al. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 2005;77:78-88.
12. Tuzun E, Sharp AJ, Bailey JA, et al. Fine-scale structural variation of the human genome. Nat Genet 2005;37:727-32.
13. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-51.
14. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science 2004;305:525-8.
15. Micci F, Teixiera MR, Haugom L, et al. Genomic aberrations in carcinomas of the uterine corpus. Genes Chromosomes Cancer 2004;40:229-46.
16. Levan K, Partheen K, Osterberg L, et al. Chromosomal alterations in 98 endometrioid carcinomas analyzed with comparative genomic hybridization. Cytogenet Genome Res 2006;115:16-22.
17. Fishman A, Shalom-Paz E, Fejgin M, et al. Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization. Int J Gynecol Cancer 2005;15:261-6.
18. Kiechle M, Jacobsen A, Schwarz-Boeger U. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer 2001;91:534-40.
19. Byrne JA, Nourse CR, Basset P, et al. Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system. Oncogene 1998;16:873-81.
20. Byrne JA, Mattei M-G, Basset P. Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52). Genomics 1996;35:523-32.
21. Colitti CV, Rodabaugh KJ, Welch WR, et al. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Oncogene 1998;16:555-9.
22. Huang LW, Garrett AP, Muto MG, et al. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol 2000;31:367-73.
23. Shridhar V, Staub J, Huntley B, et al. A novel region of deletion on chromosme 6q23.3 spanning less than 500 kb in high grade invasive epithelial ovarian cancer. Oncogene 1999;18:3913-8.
24. Park S, Lim Y, Cho B, et al. Identification and characterization of a novel/testis antigen CAGE-1. Biochim Biophys Acta 2003;1625:173-82.
25. Cuypers HT, Selten G, Berns A, et al. Assignment of the human homologue of Pim-1, a mouse gene implicated in leukemogenesis, to the pter-q12 region of chromosome 6. Hum Genet 1986;72:262-5.
26. Dhanasekaran SM, Barrette TR, Gosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001;412:822-6.
27. Liehr T, Kuhlenbaumer G, Wulf P, et al. Regional localization of the human epithelial membrane protein genes 1,2, and 3 (EMP1, EMP2, EMP3) to 12p12.3, 16p13.2 and 19q13.3. Genomics 1999;58:106-8.
28. Yousef GM, Diamandis EP. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 2000;65:184-94.
29. Yousef GM, Kyriakopoulou LG, Scorilas A, et al. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: an new independent and favorable prognostic marker. Cancer Res 2001;61:7811-8.
30. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
31. Lin SW, Ke FC, Hsiao PW, et al. Critical involvement of ILK in TGF beta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp Cell Res 2007;313:602-13.
32. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
33. Kawuchi S, Okuda S-I, Morioka H, et al. Large cell neuroendocrine carcinoma of the uterine cervix with cytogenetic analysis by comparative genomic hybridization: a case study. Hum Pathol 2005;36:1096-100.
34. Mannion C, Park W-S, Man YG, et al. Endocrine tumors of the cervix. Morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p. Cancer 1998;72:3-9.
35. Wistuba II, Thomas B, Behrens C, et al. Molecular abnormalities associated with endocrine tumors of the cervix. Gynecol Oncol 1999;72:3-9.
36. Peng W-X, Shibata T, Katoh H, et al. Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung. Cancer Sci 2005;96:661-7.
37. Welborn J, Jenks H, Taplett J, et al. High-grade neuroendocrine carcinomas display unique cytogenetics aberrations. Cancer Genet Cytogenet 2004;155:33-41.
38. Ullmann R, Schwendel A, Klemen H, et al. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization. Hum Pathol 1998;29:1145-9.